In this episode, Dr. Chi-Ming Chow provides an overview of hantavirus infections, covering cases, statistics, symptoms, and recovery processes. He discusses recent studies on semaglutide for alcohol use disorder, exploring the role of GLP-1 receptor agonists and detailing ongoing trials and future research. The episode examines red light therapy, cold plunges, and contrast therapy, addressing the risks, safety concerns, and medical advice surrounding these extreme therapies. Dr. Chow highlights a cautionary tale about dietary supplement toxicity, discussing its effects, treatment options, and the importance of regulation and consumer awareness. The episode concludes with closing remarks and a thank you.

(0:00) Introduction and overview of hantavirus infections

(1:30) Hantavirus cases, statistics, symptoms, and recovery

(3:57) Semaglutide for alcohol use disorder: studies and results

(6:03) GLP-1 receptor agonists, trial details, and future research

(8:06) Red light therapy, cold plunges, and contrast therapy

(10:04) Risks, safety, and medical advice for extreme therapies

(10:26) Dietary supplement toxicity: cautionary tale and effects

(12:16) Treatment, regulation, and consumer awareness

(13:25) Closing remarks and thank you